Capillary technologies India Limited has announced the schedule for its third quarter FY26 earnings conference call, set to take place on February 6, 2026. The AI-based cloud-native Software-as-a-Service provider will discuss its financial performance for the quarter ended December 31, 2025.

Conference Call Schedule

The earnings conference call has been scheduled following regulatory requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company filed the intimation on February 2, 2026, notifying both BSE Limited and National Stock Exchange of India Limited about the upcoming earnings call.

Management Participation

The earnings conference call will feature senior management representatives who will discuss the company's quarterly performance and address investor queries. The management team participating in the call includes key executives from various operational areas.

Registration and Access

Investors and analysts interested in participating in the earnings call can register through the company's official website. The registration link directs participants to the investor relations section at the company's finances and reports page. Post-registration, participants will receive an email containing detailed call information and access credentials.

The company has also announced that both transcript and audio recording of the earnings conference call will be made available on its website following the session. This ensures broader accessibility for stakeholders who may not be able to participate in the live call.

Company Profile

Capillary Technologies India Limited operates as a software product company specializing in artificial intelligence-based cloud-native SaaS products and solutions. The company primarily serves Enterprise Customers globally, defined as customers contributing ₹ 8.00 million in revenue from operations in a fiscal year. The company's solutions focus on developing loyalty programs for consumers and channel partners of its enterprise clients.

The company is registered with CIN L72200KA2012PLC063060 and maintains its registered office in Bengaluru, Karnataka. For investor relations queries, stakeholders can reach out to the designated contact persons including Sunil M Jain and the investor relations team at E&Y LLP.

Capillary Technologies India Limited has successfully completed its postal ballot process for the ratification of Employee Stock Option Scheme-2021 (ESOP 2021). The shareholders approved the special resolution with an overwhelming majority of 89.11% votes in favor, as confirmed through the official regulatory filing submitted to BSE and NSE on January 05, 2026.

Postal Ballot Results

The e-voting process concluded on January 04, 2026, with significant shareholder participation across different categories:

Regulatory Compliance and Documentation

The company submitted comprehensive documentation to both stock exchanges as required under Regulation 44 of SEBI Listing Regulations:

Voting Process Details

The postal ballot was conducted under strict regulatory compliance with detailed oversight:

ESOP Scheme Overview

The ratified Employee Stock Option Scheme-2021 encompasses up to 72,91,000 stock options, designed to enhance employee retention and align workforce interests with shareholder objectives. This ratification was necessitated under SEBI regulations following the company's listing on BSE and NSE.

Financial Context

To provide perspective on this corporate action, the company's recent financial position shows:

The successful ratification enables the company to proceed with its employee stock option program, supporting talent acquisition and retention strategies in the competitive technology sector. The voting results and scrutinizer's report are available on the company's investor website at capillarytech.com/investors/shareholder-information/.